
Ron Finklestien
Criteo Stock Falls 29% This Year: Is Now the Time to Invest or Should You Hold Off?
Criteo (CRTO) Faces Year-to-Date Struggles Amid Strategic Growth Initiatives Criteo (CRTO) has seen its shares decline by 29.2% year-to-date, significantly underperforming the Zacks Computer ...
CRISPR Therapeutics Partners with Firm to Advance siRNA Therapeutics
CRISPR Therapeutics Partners with Sirius on New siRNA Therapies CRISPR Therapeutics (CRSP) has announced a collaboration with privately held Sirius Therapeutics, based in San ...
“Significant Capital Injections Observed in SCHG, ACN, PGR, and AMD ETFs”
Schwab U.S. Large-Cap Growth ETF Sees $274.6 Million Inflow In the latest analysis of week-over-week changes in shares outstanding among various ETFs, the Schwab ...
“Anticipating Analog Devices’ Q2 Earnings: Key Insights and Projections”
Analog Devices Set to Report Strong Q2 Earnings on May 22 Analog Devices, Inc. (ADI) will release its second-quarter fiscal 2025 results on May ...
“Significant ETF Withdrawals: TQQQ and HYDW Experience Major Outflows”
ETFs Experience Notable Outflows This Week In the latest review of exchange-traded funds (ETFs) at ETF Channel, significant outflows were noted over the past ...










